Story perspectives

Multidrug-Resistant Candida auris Threatens NYC Amid Pandemic

3/18/2026

Summary

Story summary

Candida auris, a multidrug-resistant fungus, poses a significant health threat to New York City, with 623 clinical cases reported last year and detection dating to 2016.
The New York City-New Jersey area accounts for nearly 20% of U.S. Candida auris cases, linked to travel and trade with South Asia.
Antibiotic overuse during the COVID-19 pandemic worsened the situation.
The PASTEUR Act would incentivize antibiotic development via a subscription model.

1 of 1

Story summary

Candida auris, a multidrug-resistant fungus, poses a significant health threat to New York City, with 623 clinical cases reported last year and detection dating to 2016.
The New York City-New Jersey area accounts for nearly 20% of U.S. Candida auris cases, linked to travel and trade with South Asia.
Antibiotic overuse during the COVID-19 pandemic worsened the situation.
The PASTEUR Act would incentivize antibiotic development via a subscription model.